MLN0128 and MLN0128 + MLN1117 Compared With Everolimus in the Treatment of Adults With Advanced or Metastatic Clear-Cell Renal Cell Carcinoma
Clinical trial NCT02724020 · COMPLETED
Trial details
- NCT number
- NCT02724020
- Sponsor
- Millennium Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-06-30
- Primary completion
- 2020-02-03
- Enrollment
- 96
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.